If you need more lookups,
subscriptions start at $34 USD/month.
Steve Brannan Location
Boston, MA, US
Steve Brannan Work
CMO @ (March 2017 - Present)
Chief Medical Officer @ (March 2017 - Present)
Consultant @ N/A (July 2016 - February 2017)
VP Clinical Research and Medical Affairs @ (August 2015 - June 2016)
VP and Therapeutic Area Leader for Neuroscience, Clincal Development @ (May 2011 - August 2015)
Executive Medical Director @ (July 2008 - December 2009)
Senior Medical Director @ (February 2007 - July 2008)
Senior Medical Director @ (January 2003 - January 2007)
CRP @ Eli Lilly and Company (January 2001 - January 2003)
Assistant Professor @ UTHSCSA (January 1992 - January 2001)
Steve Brannan Education
The University of Texas Southwestern Medical Center at Dallas
M.D. (medicine)
1981-1985
Harvard University
A.B. (History and Science)
1975-1979
Steve Brannan Skills
Neuroscience
Clinical Trials
Clinical Development
Medical Affairs
Clinical Research
Drug Development
Pharmaceutical Industry
Clinical Pharmacology
Biomarkers
Medical Education
GCP
Therapeutic Areas
Lifesciences
Drug Discovery
Pharmacology
Medicine
Infectious Diseases
Diabetes
CRO
Pharmacovigilance
Medical Devices
Business Development
Life Sciences
CNS disorders
Neurology
Regulatory Affairs
CTMS
Good Clinical Practice (GCP)
Management
Good Clinical Practice Gcp
Customer Service
CRO Management
Project Management
Good Clinical Practice
Steve Brannan Summary
Steve Brannan, based in Boston, MA, US, is currently a CMO at Karuna Pharmaceuticals Inc. Steve Brannan brings experience from previous roles at Karuna Pharmaceuticals Inc, N/A, FORUM Pharmaceuticals and Takeda Pharmaceuticals. Steve Brannan holds a 1981 - 1985 M.D. in medicine @ The University of Texas Southwestern Medical Center at Dallas. With a robust skill set that includes Neuroscience, Clinical Trials, Clinical Development, Medical Affairs, Clinical Research and more. Steve Brannan has 1 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Steve Brannan?
Find contact details for 700 million professionals.